HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases
出版年份 2016 全文链接
标题
HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases
作者
关键词
-
出版物
Biomed Research International
Volume 2016, Issue -, Pages 1-15
出版商
Hindawi Limited
发表日期
2016-08-01
DOI
10.1155/2016/8797206
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Epigenetic Therapeutics: A New Weapon in the War Against Cancer
- (2016) Nita Ahuja et al. Annual Review of Medicine
- Histone deacetylase inhibitors restore IL-10 expression in lipopolysaccharide-induced cell inflammation and reduce IL-1β and IL-6 production in breast silicone implant in C57BL/6J wild-type murine model
- (2016) Rosa Di Liddo et al. AUTOIMMUNITY
- Epigenetically maintained SW13+ and SW13- subtypes have different oncogenic potential and convert with HDAC1 inhibition
- (2016) McKale R. Davis et al. BMC CANCER
- Histone Deacetylase 1 (HDAC1) Negatively Regulates Thermogenic Program in Brown Adipocytes via Coordinated Regulation of Histone H3 Lysine 27 (H3K27) Deacetylation and Methylation
- (2016) Fenfen Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Class I and IIa HDACs Mediate HIF-1α Stability Through PHD2-Dependent Mechanism, While HDAC6, a Class IIb Member, Promotes HIF-1α Transcriptional Activity in Nucleus Pulposus Cells of the Intervertebral Disc
- (2016) Zachary R Schoepflin et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Combining targeted therapy with immunotherapy. Can 1+1 equal more than 2?
- (2016) Lidia Robert et al. SEMINARS IN IMMUNOLOGY
- Histone deacetylase inhibitors as immunomodulators in cancer therapeutics
- (2016) Li Shen et al. Epigenomics
- Regulation of the p19Arf/p53 pathway by histone acetylation underlies neural stem cell behavior in senescence-prone SAMP8 mice
- (2015) Raúl Soriano-Cantón et al. AGING CELL
- New macrocyclic analogs of the natural histone deacetylase inhibitor FK228; design, synthesis and preliminary biological evaluation
- (2015) Minghong Ni et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies
- (2015) C. M. Adams et al. CANCER RESEARCH
- Biochemical, biological and structural properties of romidepsin (FK228) and its analogs as novel HDAC/PI3K dual inhibitors
- (2015) Ken Saijo et al. CANCER SCIENCE
- Histone deacetylase inhibitor valproic acid promotes the induction of pluripotency in mouse fibroblasts by suppressing reprogramming-induced senescence stress
- (2015) Yingying Zhai et al. EXPERIMENTAL CELL RESEARCH
- MicroRNA-31 Is a Transcriptional Target of Histone Deacetylase Inhibitors and a Regulator of Cellular Senescence
- (2015) Joon-Ho Cho et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HDAC inhibitor–dependent transcriptome and memory reinstatement in cognitive decline models
- (2015) Eva Benito et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA-221 governs tumor suppressor HDAC6 to potentiate malignant progression of liver cancer
- (2015) Hyun Jin Bae et al. JOURNAL OF HEPATOLOGY
- Experience Modulates the Effects of Histone Deacetylase Inhibitors on Gene and Protein Expression in the Hippocampus: Impaired Plasticity in Aging
- (2015) Angila S. Sewal et al. JOURNAL OF NEUROSCIENCE
- Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
- (2015) K.V. Woan et al. Molecular Oncology
- Epigenome-wide study identifies novel methylation loci associated with body mass index and waist circumference
- (2015) Stella Aslibekyan et al. Obesity
- Inhibiting histone deacetylase 1 suppresses both inflammation and bone loss in arthritis
- (2015) Melissa D. Cantley et al. RHEUMATOLOGY
- Cells adapt to the epigenomic disruption caused by histone deacetylase inhibitors through a coordinated, chromatin-mediated transcriptional response
- (2015) John A Halsall et al. Epigenetics & Chromatin
- Romidepsin targets multiple survival signaling pathways in malignant T cells
- (2015) B C Valdez et al. Blood Cancer Journal
- HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
- (2015) D. M. Woods et al. Cancer Immunology Research
- Valproic Acid Upregulates NKG2D Ligand Expression through an ERK-dependent Mechanism and Potentially Enhances NK Cell-mediated Lysis of Myeloma
- (2015) Xiaosong Wu et al. NEOPLASIA
- HDAC-inhibitor (S)-8 disrupts HDAC6-PP1 complex prompting A375 melanoma cell growth arrest and apoptosis
- (2014) Manjola Balliu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Harnessing the potential of epigenetic therapy to target solid tumors
- (2014) Nita Ahuja et al. JOURNAL OF CLINICAL INVESTIGATION
- A Novel Role for Histone Deacetylase 6 in the Regulation of the Tolerogenic STAT3/IL-10 Pathway in APCs
- (2014) Fengdong Cheng et al. JOURNAL OF IMMUNOLOGY
- Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cells
- (2014) Fengdong Cheng et al. MOLECULAR IMMUNOLOGY
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
- (2014) Katrina J. Falkenberg et al. NATURE REVIEWS DRUG DISCOVERY
- The growing landscape of lysine acetylation links metabolism and cell signalling
- (2014) Chunaram Choudhary et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Decreased GFAP Expression and Improved Functional Recovery in Contused Spinal Cord of Rats Following Valproic Acid Therapy
- (2014) Marzieh Darvishi et al. NEUROCHEMICAL RESEARCH
- HDAC inhibition imparts beneficial transgenerational effects in Huntington's disease mice via altered DNA and histone methylation
- (2014) Haiqun Jia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone deacetylase inhibitors
- (2013) Marije Slingerland et al. ANTI-CANCER DRUGS
- A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance
- (2013) F. Santoro et al. BLOOD
- Effects of treatment with histone deacetylase inhibitors in solid tumors: a review based on 30 clinical trials
- (2013) Tianzhu Qiu et al. Future Oncology
- Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
- (2013) Denise A. Yardley et al. JOURNAL OF CLINICAL ONCOLOGY
- Valproic Acid Protects Motor Neuron Death by Inhibiting Oxidative Stress and Endoplasmic Reticulum Stress-Mediated Cytochrome C Release after Spinal Cord Injury
- (2013) Jee Y. Lee et al. JOURNAL OF NEUROTRAUMA
- The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity
- (2013) David M. Woods et al. MELANOMA RESEARCH
- HDAC Inhibition Suppresses Primary Immune Responses, Enhances Secondary Immune Responses, and Abrogates Autoimmunity During Tumor Immunotherapy
- (2013) Byram W Bridle et al. MOLECULAR THERAPY
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
- (2013) Cigall Kadoch et al. NATURE GENETICS
- HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner
- (2013) M. Malvaez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HDAC inhibitor therapy in autoimmunity and transplantation
- (2012) Wayne W Hancock et al. ANNALS OF THE RHEUMATIC DISEASES
- Romidepsin (FK228) and its analogs directly inhibit phosphatidylinositol 3-kinase activity and potently induce apoptosis as histone deacetylase/phosphatidylinositol 3-kinase dual inhibitors
- (2012) Ken Saijo et al. CANCER SCIENCE
- HDAC Inhibitors Augmented Cell Migration and Metastasis through Induction of PKCs Leading to Identification of Low Toxicity Modalities for Combination Cancer Therapy
- (2012) K.-T. Lin et al. CLINICAL CANCER RESEARCH
- Histone Deacetylase Inhibitors: New Promise in the Treatment of Immune and Inflammatory Diseases
- (2012) Stephen J. Shuttleworth et al. CURRENT DRUG TARGETS
- Histone deacetylase 1 enhances microRNA processing via deacetylation of DGCR8
- (2012) Taeko Wada et al. EMBO REPORTS
- Three Novel Acetylation Sites in the Foxp3 Transcription Factor Regulate the Suppressive Activity of Regulatory T Cells
- (2012) H.-S. Kwon et al. JOURNAL OF IMMUNOLOGY
- SMRT-mediated co-shuttling enables export of class IIa HDACs independent of their CaM kinase phosphorylation sites
- (2012) Francesc X. Soriano et al. JOURNAL OF NEUROCHEMISTRY
- Histone deacetylases and cancer
- (2012) Bruna Barneda-Zahonero et al. Molecular Oncology
- Histone Deacetylase Inhibitors Globally Enhance H3/H4 Tail Acetylation Without Affecting H3 Lysine 56 Acetylation
- (2012) Paul Drogaris et al. Scientific Reports
- Histone deacetylase inhibitors and their potential role in inflammatory bowel diseases: Figure 1
- (2011) Alexander J.P. Edwards et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells
- (2011) Keita Nakane et al. INTERNATIONAL JOURNAL OF UROLOGY
- Unknown
- (2011) Charles Dinarello et al. MOLECULAR MEDICINE
- Unknown
- (2011) Giuseppe Faraco et al. MOLECULAR MEDICINE
- Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
- (2011) Marcus Bantscheff et al. NATURE BIOTECHNOLOGY
- Epigenetic Regulation of Thy-1 by Histone Deacetylase Inhibitor in Rat Lung Fibroblasts
- (2010) Yan Y. Sanders et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Anti-inflammatory Agents: Present and Future
- (2010) Charles A. Dinarello CELL
- Epigenetics and depression: current challenges and new therapeutic options
- (2010) Marc Schroeder et al. CURRENT OPINION IN PSYCHIATRY
- Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line
- (2010) Jennifer S Waby et al. Molecular Cancer
- Histone Deacetylase Inhibitors Stimulate Histone H3 Lysine 4 Methylation in Part Via Transcriptional Repression of Histone H3 Lysine 4 Demethylases
- (2010) P.-H. Huang et al. MOLECULAR PHARMACOLOGY
- DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines
- (2009) Melissa J LaBonte et al. BMC Medical Genomics
- E-Cadherin Regulates Metastasis of Pancreatic Cancer In Vivo and Is Suppressed by a SNAIL/HDAC1/HDAC2 Repressor Complex
- (2009) Johannes von Burstin et al. GASTROENTEROLOGY
- Epigenetic regulation of microRNA expression in colorectal cancer
- (2009) Eva Bandres et al. INTERNATIONAL JOURNAL OF CANCER
- Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer
- (2009) Suresh S. Ramalingam et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-449a targets HDAC-1 and induces growth arrest in prostate cancer
- (2009) E J Noonan et al. ONCOGENE
- Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
- (2009) C. Choudhary et al. SCIENCE
- Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
- (2008) Nagma Khan et al. BIOCHEMICAL JOURNAL
- Epigenetic Enhancement of Antigen Processing and Presentation Promotes Immune Recognition of Tumors
- (2008) A. F. Setiadi et al. CANCER RESEARCH
- Histone deacetylase 11 regulates oligodendrocyte-specific gene expression and cell development in OL-1 oligodendroglia cells
- (2008) Hedi Liu et al. GLIA
- HDAC6 Is Required for Epidermal Growth Factor-induced β-Catenin Nuclear Localization
- (2008) Yu Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo
- (2008) M. Fournel et al. MOLECULAR CANCER THERAPEUTICS
- The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance
- (2008) Alejandro Villagra et al. NATURE IMMUNOLOGY
- Repression of E-cadherin by the polycomb group protein EZH2 in cancer
- (2008) Q Cao et al. ONCOGENE
- A homogeneous cellular histone deacetylase assay suitable for compound profiling and robotic screening
- (2007) Thomas Ciossek et al. ANALYTICAL BIOCHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now